BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Flexsteel Industries
FLXS
$301M
| $35.3K | ﹤0.01% |
1,770
+580
| +49% | +$10.1K |
|
3702
American Superconductor
AMSC
$1.56B
| $35.2K | ﹤0.01% |
4,482
+1,829
| +69% | +$14.7K |
|
3703
Alico
ALCO
$308M
| $35.1K | ﹤0.01% |
981
+417
| +74% | +$14K |
|
3704
Fidelity D&D Bancorp
FDBC
$322M
| $34.9K | ﹤0.01% |
561
+103
| +22% | +$6.69K |
|
3705
Standard BioTools
LAB
$312M
| $34.9K | ﹤0.01% |
10,016
+127
| +1% | +$447 |
|
3706
Accuray
ARAY
$33.4M
| $34.8K | ﹤0.01% |
12,329
-1,634
| -12% | -$4.54K |
|
|
DSKE
3707
DELISTED
Daseke, Inc. Common Stock
DSKE
| $34.7K | ﹤0.01% |
10,986
+4,178
| +61% | +$12.2K |
|
3708
Cadiz
CDZI
$292M
| $34.7K | ﹤0.01% |
3,147
-26
| -0.8% | -$300 |
|
3709
Esquire Financial Holdings
ESQ
$1.61B
| $34.7K | ﹤0.01% |
1,330
+328
| +33% | +$8.01K |
|
3710
Nexa Resources
NEXA
$1.93B
| $34.5K | ﹤0.01% |
4,239
-787
| -16% | -$7.18K |
|
|
FNCB
3711
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $34.5K | ﹤0.01% |
4,083
+1,921
| +89% | +$15.1K |
|
|
RYZ
3712
Ryerson Holding Corp
RYZ
$1.5B
| $34.5K | ﹤0.01% |
2,915
+346
| +13% | +$3.42K |
|
3713
LifeVantage
LFVN
$82.1M
| $34.5K | ﹤0.01% |
2,209
+444
| +25% | +$6.53K |
|
3714
Hawthorn Bancshares
HWBK
$276M
| $34.4K | ﹤0.01% |
1,578
+742
| +89% | +$15.4K |
|
3715
Dianthus Therapeutics
DNTH
$6.29B
| $34.3K | ﹤0.01% |
142
-19
| -12% | -$3.55K |
|
3716
Turning Point Brands
TPB
$1.73B
| $34.3K | ﹤0.01% |
1,200
-101
| -8% | -$2.53K |
|
|
TEF
3717
DELISTED
Telefonica
TEF
| $34.2K | ﹤0.01% |
6,075
+604
| +11% | +$3.67K |
|
|
JNCE
3718
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $34K | ﹤0.01% |
3,900
+1,311
| +51% | +$7.09K |
|
3719
Talphera
TLPH
$72.7M
| $34K | ﹤0.01% |
806
+308
| +62% | +$12.6K |
|
3720
KB Financial Group
KB
$41.4B
| $34K | ﹤0.01% |
821
+215
| +35% | +$8.22K |
|
|
AGNT
3721
AGNT Inc
AGNT
$715M
| $34K | ﹤0.01% |
5,994
+1,940
| +48% | +$9.64K |
|
|
CBMG
3722
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $33.9K | ﹤0.01% |
2,088
+162
| +8% | +$2.7K |
|
3723
BlueLinx
BXC
$701M
| $33.7K | ﹤0.01% |
2,364
+930
| +65% | +$19.1K |
|
3724
Mitek Systems
MITK
$838M
| $33.6K | ﹤0.01% |
4,388
-1,180
| -21% | -$9.95K |
|
3725
PUT
Baxter International
BAX
$13.9B
| $33.4K | ﹤0.01% |
4
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.